This year’s ADA Pathway to Stop Diabetes Symposium features six recent award recipients, who will discuss their research supported by the Pathway to Stop Diabetes® initiative. The two-hour s... Read more
Continuous glucose monitoring (CGM) outcomes provide meaningful metrics for clinical trials and diabetes care, but the benefits can’t be demonstrated without a standard set of definitions, a... Read more
Although the latest high-density lipoprotein (HDL) clinical trials have not shown protection against cardiovascular disease, HDL research needs to continue, according to Alan T. Remaley, MD,... Read more
Sometimes too much of a good thing is not so good. Such is the case with intensive glycemic control in certain populations. Saturday’s symposium Overtreatment in Diabetes Management will exa... Read more
During Saturday’s symposium Population Health, Affordable Care Act (ACA), and New Approaches for Dissemination/Implementation of the Diabetes Prevention Program (DPP), four experts will shar... Read more
Diabetes is a lifestyle disease that requires the person living with the disease to make many daily decisions about diet, activity level, and medications, as well as adequate support to [... Read more
Emerging data show that the gut and the gut microbiome play key roles in metabolic health. From glucose and lipid metabolism to fatty liver disease, obesity, and other conditions, intestinal... Read more
During Saturday’s two-hour symposium Diabetes, Drugs and Heart Failure, which begins at 1:45 p.m. in Hall A, four experts will discuss several novel diabetes medications and their impact on... Read more
Researchers have tried many approaches to induce beta cells to proliferate and improve function, and most have failed. But several new approaches have emerged, including embryonic stem cells... Read more
The American Diabetes Association’s 77th Scientific Sessions will be held June 9-13, 2017, at the San Diego Convention Center in San Diego, California. In the final weeks before the meeting,... Read more